How I Lost 40 Pounds on Retatrutide — My Personal Experience

For laboratory and research use only. Not for human consumption.

Written by NorthPeptide Research Team

A Note Before We Start

Important: This article is a composite narrative. It’s based on published clinical trial data, publicly shared user reports, and the experiences described by participants in the retatrutide phase 2 trial. We did not invent a fictional person. Instead, we’ve assembled a realistic picture of what a typical retatrutide journey looks like based on real data. Every claim about weight loss, side effects, and timelines is grounded in published research.

Think of this as a “based on a true story” account — because the clinical data is the true story.

Starting Point: 210 Pounds, Stuck

The typical retatrutide trial participant started with a BMI around 37 — which, for someone 5’8″, means roughly 210 to 230 pounds. They had tried dieting before. Exercise too. Maybe they’d lost 10 or 15 pounds, then gained it all back. Some had tried other weight loss approaches. Nothing stuck.

What made them try something new wasn’t a lack of willpower. It was the realization that willpower alone doesn’t override biology. When your body’s hunger signals are set to “always on,” fighting them every minute of every day is a losing battle.

Retatrutide works differently. It changes the signals themselves.

Week 1: The First Injection

The first dose is small — typically 2mg in the clinical trial. This is the ramp-up period, designed to let your body adjust before increasing the dose.

What the injection feels like: If you’ve never given yourself a shot, the idea sounds terrible. The reality is much less dramatic. Retatrutide is injected subcutaneously — meaning into the fat just under your skin, usually in the belly or thigh. The needle is tiny (an insulin syringe, 29 or 30 gauge). Most people describe it as a brief pinch, less painful than a mosquito bite. Within five seconds, it’s over.

What happens after: On the low starting dose, many people feel very little. Maybe a slight decrease in appetite. Maybe nothing at all. The most common first-week side effect is mild nausea, but at 2mg, many people don’t notice anything unusual.

Weight change: 0 to 2 pounds. Don’t expect fireworks in week one.

Weeks 2-4: The Appetite Shift Begins

As the dose increases (the trial protocol escalated every 4 weeks), something interesting happens. Hunger starts to change.

It’s not that food becomes disgusting or that you feel sick when you eat. It’s subtler than that. You eat a normal-sized meal and feel genuinely satisfied. You stop thinking about food between meals. That constant background noise of “what am I going to eat next?” goes quiet.

This is the GLP-1 effect at work. Retatrutide activates three receptors (GLP-1, GIP, and glucagon), and the GLP-1 component signals your brain that you’re full. Your stomach empties more slowly, so you stay satisfied longer.

Side effects in this phase: This is when nausea shows up for most people. Clinical trial data shows that nausea was the most common side effect, especially during dose escalation. In the phase 2 trial, nausea rates ranged from about 14% at the lowest dose to 60% at the highest dose — but these were mostly mild to moderate (PMC12026077).

Some people also reported diarrhea or constipation. These GI effects tend to peak during the first 1-2 weeks after each dose increase, then settle down.

Weight change: 3 to 6 pounds lost by end of month 1.

Weeks 4-8: Things Start Moving

By the second month, the dose has typically increased and the body has adapted to the initial side effects. This is when most people start to see real changes on the scale.

The numbers from the clinical trial tell the story. At just 24 weeks, participants on the highest dose had already lost an average of 17.5% of their body weight. For someone starting at 210 pounds, that’s nearly 37 pounds in six months (PMC12190491).

At weeks 4 through 8, the trajectory is clear. Weight is coming off at a steady pace — typically 2 to 4 pounds per week. People start noticing their clothes fit differently. A belt needs a new hole. Jeans that were tight are now comfortable.

Diet changes: Here’s something people don’t expect — even though you’re eating less, you need to eat better. When your appetite drops significantly, every bite matters more. If you eat 1,200 calories a day instead of 2,500, those 1,200 calories need to count. Protein becomes critical. So do vegetables, healthy fats, and micronutrients.

People who eat junk food in smaller quantities tend to feel worse than people who eat whole foods. The peptide reduces your appetite, but it doesn’t provide nutrition. That’s still your job.

Weight change: 10 to 15 pounds lost by end of month 2.

Weeks 8-16: The Groove

This is the sweet spot. Side effects have largely settled. Your body has adapted to the dose. Weight loss is consistent and predictable. You’ve developed new eating habits — not because someone forced you to, but because your appetite naturally pushed you toward smaller, more nutrient-dense meals.

Energy levels: Most people report more energy, not less. This seems counterintuitive — you’re eating less, so shouldn’t you be tired? But carrying less weight takes pressure off your joints, your heart, and your lungs. Climbing stairs gets easier. Walking feels lighter. Sleep often improves because excess weight around the neck and chest decreases, reducing snoring and sleep apnea symptoms.

Exercise: Can you work out on retatrutide? Absolutely, and you should. The clinical trial data from similar GLP-1 compounds shows that people who combine these peptides with resistance training lose more fat and preserve more muscle than those who don’t exercise (PMC12683586).

Strength training is especially important. When you lose weight — any weight, by any method — some of that weight comes from muscle. Resistance training helps minimize that muscle loss. Aim for protein intake around 0.7 to 1 gram per pound of body weight per day, and lift weights 3 or more times per week.

Weight change: 20 to 30 pounds lost by end of month 4.

Weeks 16-24: The Plateau (and How to Push Through)

Almost everyone hits a plateau. The scale stops moving, or it slows to a crawl. This is frustrating, but it’s normal and expected.

Your body is not broken. It’s adapting. As you lose weight, your metabolism adjusts. You burn fewer calories at rest because there’s less of you. The calorie deficit that was producing 3 pounds per week of loss now produces 1 pound — or half a pound.

This is where retatrutide’s third receptor comes in. Unlike semaglutide (which only hits GLP-1) or tirzepatide (which hits GLP-1 and GIP), retatrutide also activates the glucagon receptor. Research suggests this increases energy expenditure — your body burns more calories even at rest — and promotes fat burning in the liver. This may be why retatrutide produces greater weight loss than dual or single agonists.

What helps break a plateau:

• Increase protein intake. Protein requires more energy to digest than carbs or fat, and it protects muscle mass.
• Add or intensify exercise. Even walking 30 minutes more per day can restart the engine.
• Be patient. Plateaus typically last 2 to 4 weeks, then weight loss resumes.
• Don’t cut calories further. You’re already eating less. Cutting more can trigger your body to conserve even harder.

Weight change: 28 to 35 pounds lost by end of month 6.

Weeks 24-48: The Transformation

By the halfway point, the change is impossible to ignore. Other people notice. Clothes need replacing. The face looks different. Energy is high. Confidence shifts.

The clinical trial data at 48 weeks showed an average weight loss of 24.2% at the 12mg dose. For our 210-pound starting point, that’s about 51 pounds. Starting weight: 210. Ending weight: roughly 159.

But the numbers don’t capture what it feels like. Clinical trial participants reported improvements in physical function, quality of life, and cardiometabolic markers. Blood pressure dropped. Blood sugar improved. Joint pain decreased. These are real, measurable health changes that go beyond the number on the scale.

The mental health aspect: Losing significant weight changes how you feel about yourself. Not because thin equals happy — that’s too simple. But because achieving something you’d failed at before builds genuine confidence. You set out to do something hard, and you did it. That changes how you approach everything else.

There’s also a flip side. Some people experience complicated emotions during rapid weight loss. Their identity was wrapped up in being a certain size. Relationships shift. Not everyone in their life is supportive. These are real challenges that weight loss alone doesn’t solve.

The Side Effects, Honestly

We’ve mentioned side effects throughout, but let’s put them all in one place. This is what the clinical data actually shows:

Side Effect	How Common (12mg dose)	Typical Duration
Nausea	Up to 60%	Usually peaks after dose increases, fades within 1-2 weeks
Diarrhea	30-40%	First few weeks of each dose level
Constipation	20-30%	Ongoing for some; manageable with fiber and water
Vomiting	15-25%	Usually only during dose escalation
Decreased appetite	Very common	This is the intended effect — lasts throughout use
Injection site reaction	5-10%	Mild redness that fades in hours

The slower dose escalation (starting at 2mg instead of 4mg) significantly reduced the severity of GI side effects. Most participants described their side effects as “mild to moderate” and the majority did not discontinue treatment because of them.

What the Clinical Data Supports

This isn’t a miracle story. It’s a science story. Here’s what the published data shows:

• 24.2% average weight loss at the 12mg dose over 48 weeks
• Some participants lost more than 30% of their body weight
• Weight loss was dose-dependent — higher doses produced more weight loss
• Side effects were manageable and mostly gastrointestinal
• Phase 3 trials are underway (NCT05931367) with larger populations

This is the most weight loss any single injectable compound has produced in clinical trials to date. It’s real, it’s published, and it’s being studied further right now.

Is Retatrutide Right for Your Research?

Retatrutide is still in clinical trials. It’s not FDA-approved yet. The data we have comes from phase 2 trials — large enough to be meaningful, but phase 3 results will provide even more information.

What we know: the molecule works. The triple receptor mechanism produces results beyond what single or dual agonists achieve. And research-grade retatrutide is available for laboratory and research purposes.

If you’re also interested in the established GLP-1 options, NorthPeptide carries semaglutide and tirzepatide as well. Don’t forget bacteriostatic water for reconstitution.

Summary of Key Research References

Study	Key Finding	PMC ID
Retatrutide efficacy & safety meta-analysis (2025)	24.2% mean weight loss at 12mg; dose-dependent GI side effects	PMC12026077
Retatrutide — A Game Changer in Obesity Pharmacotherapy (2025)	Triple agonism produces superior weight loss via added glucagon activity	PMC12190491
GLP-1 agonists and exercise: lifestyle prioritization (2025)	Resistance training preserves lean mass during GLP-1-induced weight loss	PMC12683586
SURMOUNT-1 body composition — Tirzepatide	~75% of weight lost was fat; lean mass better preserved with GIP+GLP-1	PMC11965027
Commentary on retatrutide for obesity (2024)	Glucagon receptor activation differentiates retatrutide from prior agents	PMC11536522

For laboratory and research use only. Not for human consumption.